INS and metabolic dysfunction-associated steatotic liver disease: On the contrary, FLI has proved to represent an easy screening tool to identify NAFLD in patients with cardio-metabolic risk factors where ultrasound is unavailable [21,56,57], which is associated with reduced insulin sensitivity, and increased risk of T2DM, atherosclerosis, and cardiovascular disease [43].